Treatment of Wegener's Granulomatosis With Cyclophosphamide
An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies
|3||Active, not recruiting||
Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides
† Study has passed its completion date and status has not been verified in more than two years.